Vincerx Pharma, Inc. Increase (Decrease) in Other Noncurrent Liabilities
Vincerx Pharma, Inc. reported Increase (Decrease) in Other Noncurrent Liabilities of -$50.00 thousand for the 12-month period ending 2024-12-31, per its 10-K filed 2025-03-27.
Financial Statements › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInOtherNoncurrentLiabilities · last filed 2025-03-27
- Vincerx Pharma, Inc. increase (decrease) in other noncurrent liabilities for the quarter ending 2023-12-31 was $0.00.
- Vincerx Pharma, Inc. increase (decrease) in other noncurrent liabilities for the quarter ending 2022-12-31 was $0.00.
- Vincerx Pharma, Inc. increase (decrease) in other noncurrent liabilities for the quarter ending 2021-12-31 was $0.00.
- Vincerx Pharma, Inc. increase (decrease) in other noncurrent liabilities for fiscal 2024 was -$50.00K.
- Vincerx Pharma, Inc. increase (decrease) in other noncurrent liabilities for fiscal 2023 was $0.00, a 100.00% decline from fiscal 2022.
- Vincerx Pharma, Inc. increase (decrease) in other noncurrent liabilities for fiscal 2022 was $50.00K.
- Vincerx Pharma, Inc. increase (decrease) in other noncurrent liabilities for fiscal 2021 was $0.00.
| Period end | Increase (Decrease) in Other Noncurrent Liabilities 3 month | Increase (Decrease) in Other Noncurrent Liabilities 9 month | Increase (Decrease) in Other Noncurrent Liabilities 12 month |
|---|---|---|---|
| 2024-12-31 | -$50.00K 10-K · filed 2025-03-27 | ||
| 2023-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-27 | $0.00 10-K · filed 2025-03-27 | |
| 2023-09-30 | $0.00 10-Q · filed 2023-11-14 | ||
| 2022-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-29 | $50.00K 10-K · filed 2024-03-29 | |
| 2022-09-30 | $50.00K 10-Q · filed 2023-11-14 | ||
| 2021-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-28 | $0.00 10-K · filed 2023-03-28 | |
| 2021-09-30 | $0.00 10-Q · filed 2022-11-10 |